Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Clinical review of risperidone

G Chouinard¹, W Arnott

¹Department of Psychiatry, University of Montreal, Quebec.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie

|September 1, 1993

Summary

Risperidone is a potent antipsychotic effective for schizophrenia, showing rapid action and a favorable side-effect profile. Long-term use maintains therapeutic benefits without significant neurological issues common with older neuroleptics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[In process].

Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2018

Same author

Phytophagy by the Mullein Bug (Hemiptera: Miridae) on Apples: Feeding Behavior and Fruit Damage.

Journal of economic entomology·2016

Same author

[Iatrogenic psychiatric-like symptoms recognition].

L'Encephale·2010

Same author

Death attributed to ventricular arrhythmia.

Canadian Medical Association journal·2010

Same author

Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neuroleptics.

European psychiatry : the journal of the Association of European Psychiatrists·2009

Same author

Foliar Sprays with Steinernema carpocapsae against Early-season Apple Pests.

Journal of nematology·2009

Area of Science:

Psychiatry and Pharmacology
Neuroscience

Background:

Schizophrenia treatment often involves managing positive and negative symptoms.
Standard neuroleptics can cause significant neurological side-effects, including extrapyramidal symptoms (EPS).

Purpose of the Study:

To evaluate the efficacy and tolerability of risperidone in Phase II clinical trials for schizophrenia.
To assess the long-term maintenance of therapeutic effects and safety profile of risperidone.

Main Methods:

Phase II clinical trials were conducted to assess risperidone's antipsychotic properties.
Data collection included evaluation of positive and negative symptoms, extrapyramidal symptoms, and parkinsonism.

Main Results:

Risperidone demonstrated potent antipsychotic effects, improving both positive and negative symptoms of schizophrenia.
The drug exhibited a low potential for inducing extrapyramidal symptoms and possibly an antidyskinetic effect.
One-year data indicated sustained therapeutic action in chronic schizophrenia patients without significant neurological side-effects.

Conclusions:

Risperidone offers a favorable side-effect profile compared to standard neuroleptics.
Its rapid onset and sustained efficacy make it a promising treatment option for schizophrenia.

Related Experiment Videos